MARKET WIRE NEWS

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-08 10:12:17 ET

Achieve Life Sciences, Inc. (ACHV)

Q2 2025 Earnings Call

August 7, 2025 8:30 A.M. ET

Company Participants

Cindy Jacobs - Former President & Chief Medical Officer

Jaime Xinos - Chief Commercial Officer

Mark K. Oki - Chief Financial Officer

Nicole Jones - Corporate Participant

Richard A. B. Stewart - CEO & Executive Director

Conference Call Participants

Boris Tolkachev - Freedom Broker, Research Division

Gary Jay Nachman - Raymond James & Associates, Inc., Research Division

John D. Vandermosten - Zacks Small-Cap Research

Justin Howard Walsh - JonesTrading Institutional Services, LLC, Research Division...

Read the full article on Seeking Alpha

For further details see:

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript
Achieve Life Sciences Inc.

NASDAQ: ACHV

ACHV Trading

-2.55% G/L:

$4.0929 Last:

214,986 Volume:

$4.18 Open:

mwn-app Ad 300

ACHV Latest News

March 09, 2026 06:33:22 pm
ACHV - Historical Earnings Price Analysis

ACHV Stock Data

$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App